Correction: Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial

• Armin Attar,
• Mohsen Farjoud Kouhanjani,
• Kamran Hessami,
• Massoud Vosough,
• Javad Kojuri,
• Mani Ramzi,
• Seyed Ali Hosseini,
• Marjan Faghih,
• Ahmad Monabati

Affiliations

Armin Attar

Department of Cardiovascular Medicine, TAHA Clinical Trial Group, School of Medicine, Shiraz University of Medical Sciences

Mohsen Farjoud Kouhanjani

School of Medicine, Shiraz University of Medical Sciences

Kamran Hessami

School of Medicine, Shiraz University of Medical Sciences

Massoud Vosough

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR

Javad Kojuri

Department of Cardiovascular Medicine, Shiraz University of Medical Sciences

Mani Ramzi

Hematopathology and Molecular Pathology Service, Department of Pathology, Hematology Research Center, Shiraz University of Medical Sciences

Seyed Ali Hosseini

School of Medicine, Shiraz University of Medical Sciences

Marjan Faghih

Department of Biostatistics, School of Medicine, Arak University of Medical Sciences

Ahmad Monabati

Hematopathology and Molecular Pathology Service, Department of Pathology, Hematology Research Center, Shiraz University of Medical Sciences